News Search Results
Sep 14, 2025, 20:00 ET Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
China, Sept. 14, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the
More news about: Lion TCR
Sep 13, 2025, 16:32 ET Mars Snacking y Unreasonable Group dan la bienvenida a catorce nuevas empresas a Unreasonable Food™
Debut Biotechnology: fermenta ingredientes de alto valor, incluidas alternativas de color natural, para reemplazar fuentes sintéticas o que no son sostenibles.
More news about: Mars
Sep 13, 2025, 16:22 ET Mars Snacking e o Unreasonable Group dão as boas-vindas a quatorze novos empreendimentos da Unreasonable Food™
Debut Biotechnology : fermentação de ingredientes de alto valor, incluindo alternativas de cor natural, para substituir fontes insustentáveis ou sintéticas.
More news about: Mars
Sep 13, 2025, 16:10 ET Mars Snacking y Unreasonable Group dan la bienvenida a catorce nuevas empresas a Unreasonable Food™
Debut Biotechnology: Fermentación de ingredientes de alto valor, incluyendo colorantes naturales alternativos, para reemplazar fuentes insostenibles o sintéticas.
More news about: Mars
Sep 13, 2025, 16:08 ET Mars SnackingとUnreasonable Group、Unreasonable Food™に14の新規ベンチャーを迎える
Debut Biotechnology: 天然の代替着色料を含む高付加価値原料を発酵させ、持続不可能または合成の原料を置き換えます。
More news about: Mars
Sep 13, 2025, 16:04 ET Mars Snacking et Unreasonable Group accueillent quatorze nouvelles entreprises au sein d'Unreasonable Food™
Debut Biotechnology : la fermentation d'ingrédients de grande valeur, y compris des colorants naturels, pour remplacer les sources non durables ou synthétiques.
More news about: Mars
Sep 13, 2025, 16:01 ET Mars Snacking und Unreasonable Group begrüßen vierzehn neue Unternehmen bei Unreasonable Food™
Debut Biotechnology: Fermentierung von hochwertigen Inhaltsstoffen, einschließlich natürlicher Farbalternativen, um nicht nachhaltige oder synthetische Quellen zu
More news about: Mars
Sep 13, 2025, 11:20 ET Radioligand Therapy (RLT) Market worth US$10.9 billion by 2035 with 13.2% CAGR | MarketsandMarkets™
driven by its advanced healthcare infrastructure, high adoption of innovative oncology treatments, and strong presence of leading pharmaceutical and biotechnology companies. The region benefits from early approvals of key radioligand therapies, including Lutetium-177-based products, and a well-established
More news about: MarketsandMarkets
Sep 13, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Sep 12, 2025, 19:04 ET 마즈 스내킹과 언리즈너블 그룹, 언리즈너블 푸드™에 참여할 14개 신규 벤처기업 선발
데뷰 바이오테크놀로지(Debut Biotechnology): 지속 불가능하거나 합성 원료를 대체하기 위해 천연 색소 대체재 등 고부가가치 원료를 발효한다.
More news about: Mars
Sep 12, 2025, 17:33 ET The National Institute of Biomedical Research and Ridgeback Biotherapeutics Respond to 16th Ebola Outbreak in the Democratic Republic of Congo
About Ridgeback BiotherapeuticsHeadquartered in Miami, Florida, Ridgeback Biotherapeutics LP is a biotechnology company focused on emerging infectious diseases. Ridgeback developed Ebanga™ for the treatment of Ebola virus disease caused by Orthoebolavirus
More news about: Ridgeback Biotherapeutics LP
Sep 12, 2025, 17:30 ET Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™
Debut Biotechnology: Fermenting high-value ingredients, including natural color alternatives, to replace unsustainable or synthetic sources.
More news about: Mars
Sep 12, 2025, 17:00 ET Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™
Debut Biotechnology: Fermenting high-value ingredients, including natural color alternatives, to replace unsustainable or synthetic sources.
More news about: Mars
Sep 12, 2025, 11:47 ET ZINZINO AB (PUBL.): ZINZINO ACQUIRES BODĒ PRO TO INCREASE DISTRIBUTION POWER IN NORTH AMERICA AND JAPAN
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales. Bodē Pro is a global direct sales company in the health segment,
More news about: Zinzino
Sep 12, 2025, 11:30 ET School Uniform Market Size Is Expected to Reach US$58.61 Billion By 2031, at A CAGR of 6.1% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 12, 2025, 11:01 ET Demineralized Whey Powder Market Is Expected to Reach US$1,068.30 Million By 2031 at CAGR Of 5.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 12, 2025, 10:30 ET Data Bus Market Size to Reach US$32.07 Billion By 2031; It Is Estimated to Record A CAGR of 5.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 12, 2025, 10:01 ET Ligase Enzymes Market worth US$0.36 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
North America accounted for the largest share of the global ligase enzymes market, driven by its well-established biotechnology and pharmaceutical industries, strong presence of leading sequencing and molecular diagnostics companies, and significant investments in genomics
More news about: MarketsandMarkets
Sep 12, 2025, 10:01 ET Cystoscopy and Ureteroscopy Market is Expected to Reach US$ 729.30 Million By 2031, At CAGR Of 6.9% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 12, 2025, 10:00 ET INTERNATIONALLY RECOGNIZED MALARIA RESEARCHER STEFAN KAPPE, PHD, APPOINTED NEW DIRECTOR OF THE UM SCHOOL OF MEDICINE'S CENTER FOR VACCINE DEVELOPMENT AND GLOBAL HEALTH
engineer live attenuated Plasmodium parasites to develop safer and more effective malaria vaccines. Last year, his lab collaborated with biotechnology company
More news about: University of Maryland Medical Center
Sep 12, 2025, 09:52 ET Fermenta Granted Process Patent for Plant-Based Vitamin D3
contribute to global wellness." This milestone not only strengthens Fermenta's competitive moat but also diversifies its pioneering legacy in biotechnology and nutrition, supporting its vision to address global nutrition gaps while maintaining scientific excellence and sustainability leadership.
More news about: Fermenta Biotech Limited
Sep 12, 2025, 09:30 ET Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines
US$8.7 million with Xinke Future Biotechnology (Bazhou) Co., Ltd. for the research and development of "microalgae-derived extracellular vesicles" technology. Separately, a delegation from Singapore's leading biotechnology company, BICC, completed a productive site
More news about: Shineco,Inc.
Sep 12, 2025, 09:00 ET Alkermes Appoints Joshua Reed as Chief Financial Officer
brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics, a then publicly-traded biotechnology company. Prior to that, he was the CFO at Aldeyra Therapeutics. Earlier in his career,
More news about: Alkermes plc
Sep 12, 2025, 07:30 ET Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring
agricultural industry knowledge and proven track record in leading major agricultural enterprises will be invaluable as we continue to expand our biotechnology seed pipeline and market presence. Mr. Hau's extensive financial expertise and corporate governance experience will strengthen our oversight capabilities
More news about: Origin Agritech Limited
Sep 12, 2025, 06:42 ET Weekly Recap: 12 Health Press Releases You Need to See
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment"Lilly
More news about: PR Newswire